These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 9949334)

  • 1. Teratology: general considerations and principles.
    Finnell RH
    J Allergy Clin Immunol; 1999 Feb; 103(2 Pt 2):S337-42. PubMed ID: 9949334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Wilson's principles--a base of modern teratology].
    Burdan F; Bełzek A; Szumiło J; Dudka J; Korobowicz A; Tokarska E; Klepacz L; Bełzek M; Klepacz R
    Pol Merkur Lekarski; 2006 Mar; 20(117):358-61. PubMed ID: 16780275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Environmental causes of human congenital malformations: the pediatrician's role in dealing with these complex clinical problems caused by a multiplicity of environmental and genetic factors.
    Brent RL
    Pediatrics; 2004 Apr; 113(4 Suppl):957-68. PubMed ID: 15060188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Teratology and epidemiology in the study of environmental teratogens].
    Cayré R; Sánchez-Gómez C; Moreno-Rodríguez RA; de la Cruz MV
    Bol Med Hosp Infant Mex; 1992 Jul; 49(7):397-403. PubMed ID: 1418645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical teratology.
    Brent RL; Beckman DA; Landel CP
    Curr Opin Pediatr; 1993 Apr; 5(2):201-11. PubMed ID: 8374640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal exposure to teratogenic medications in the era of Risk Evaluation and Mitigation Strategies.
    Sarayani A; Albogami Y; Thai TN; Smolinski NE; Patel P; Wang Y; Nduaguba S; Rasmussen SA; Winterstein AG
    Am J Obstet Gynecol; 2022 Aug; 227(2):263.e1-263.e38. PubMed ID: 35032444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse environmental exposures in pregnancy: teratology in adolescent medicine practice.
    Seaver LH
    Adolesc Med; 2002 Jun; 13(2):269-91, vi. PubMed ID: 11986036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic basis of susceptibility to teratogen induced birth defects.
    Wlodarczyk BJ; Palacios AM; Chapa CJ; Zhu H; George TM; Finnell RH
    Am J Med Genet C Semin Med Genet; 2011 Aug; 157C(3):215-26. PubMed ID: 21766441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Teratogens and teratogenesis: general principles of clinical teratology.
    Frias JL; Thomas IT
    Ann Clin Lab Sci; 1988; 18(2):174-9. PubMed ID: 3289471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Principles of human teratology: drug, chemical, and infectious exposure.
    Wilson RD; ;
    J Obstet Gynaecol Can; 2007 Nov; 29(11):911-917. PubMed ID: 17977495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of Gross Fetal Malformations: The Modernized Wilson Technique and Skeletal Staining.
    Seegmiller RE; Cook N; Goodwin K; Leishman T; Graf M
    Methods Mol Biol; 2019; 1965():421-434. PubMed ID: 31069690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arrhenius thermodynamics and birth defects: chemical teratogen synergy. Untested, testable, and projected relevance.
    Miller MW; Church CC
    Birth Defects Res C Embryo Today; 2013 Mar; 99(1):50-60. PubMed ID: 23723172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Theoretical and applied aspects of experimental teratology].
    Dyban AP
    Ontogenez; 1977; 8(6):582-98. PubMed ID: 414184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular basis of environmentally induced birth defects.
    Finnell RH; Waes JG; Eudy JD; Rosenquist TH
    Annu Rev Pharmacol Toxicol; 2002; 42():181-208. PubMed ID: 11807170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of known environmental teratogens: drugs and chemicals.
    Beckman DA; Brent RL
    Clin Perinatol; 1986 Sep; 13(3):649-87. PubMed ID: 3533369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical period for a teratogenic VLA-4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non-teratogenic VLA-4 antagonists.
    Crofts F; Rohatagi S; Pino M; DeLise B; Zhang J; Nguyen M; Guittin P; Barbellion S; Brunel P; Hofmann T; Schmidt J; Wong M; Lockey P; Lerman S; Clark R
    Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):69-79. PubMed ID: 15098200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Teratogens during pregnancy].
    Jancárková N; Gregor V
    Ceska Gynekol; 2000 May; 65(3):188-94. PubMed ID: 10953498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of case reports in human teratology.
    Goldberg JD; Golbus MS
    Am J Obstet Gynecol; 1986 Mar; 154(3):479-82. PubMed ID: 3456709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human teratogens: update 2010.
    Holmes LB
    Birth Defects Res A Clin Mol Teratol; 2011 Jan; 91(1):1-7. PubMed ID: 21254353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How do we know if an exposure is actually teratogenic in humans?
    Friedman JM
    Am J Med Genet C Semin Med Genet; 2011 Aug; 157C(3):170-4. PubMed ID: 21766430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.